AI-ECG Algorithm Technology

Offering the promise of early detection, enhanced interpretation, and the potential for improved patient care through clinically validated AI-ECG algorithms.

Heart disease represents the most significant disease burden and cost in healthcare and is the leading cause of death. The major challenge is early identification, as heart disease is only generally symptomatic at an advanced stage.

Artificial Intelligence-Enhanced Electrocardiography (AI-ECG) offers the opportunity to transform cardiovascular medicine and revolutionize the detection of heart disease. The electrical signal of the heart is rich in information that cannot be seen by the human eye. AI enables analysis of this hidden data and creation of diagnostic algorithms.

MyoVista Insights Platform

Cloud-based, device-agnostic platform delivering AI-ECG algorithms across millions of existing ECG devices worldwide. Seamlessly integrates with EHR systems for instant results.

  • Device agnostic - works with existing ECG equipment
  • Instant cloud-based processing
  • SaaS model - pay only for what you use
  • Secure, HIPAA-compliant infrastructure

MyoVista wavECG Device

Full-featured 12-lead resting ECG with built-in AI-ECG technology. Portable, intuitive, and software upgradable to incorporate future algorithms.

  • AI-ECG impaired cardiac relaxation algorithm
  • Glasgow interpretative analysis
  • Standard AHA/IEC lead placement
  • Advanced Continuous Wavelet Transform processing

AI-ECG Algorithm Portfolio

Industry-leading library of AI algorithms transforming the standard ECG into a comprehensive cardiac screening tool.

Pre-FDA Submission

Low Ejection Fraction

Detection of reduced left ventricular ejection fraction, a key indicator of heart failure.

Preserved Ejection Fraction

Identification of heart failure with preserved ejection fraction (HFpEF).

Impaired Cardiac Relaxation

Early detection of diastolic dysfunction associated with hypertension, diabetes, and heart failure.

In Development

Mitral Valve Regurgitation
Aortic Stenosis
Pulmonary Embolism
RV Size & Function (MRI)
RV Dysfunction (Echo)
Hypertrophic Cardiomyopathy
STEMI Detection
PVC-Related Cardiomyopathy

MyoVista Insights Platform

Cloud-based, hardware-agnostic platform delivering AI-ECG algorithms across millions of existing ECG devices worldwide. Seamless EHR integration enables AI-enhanced cardiac screening at scale.

  • Device agnostic - works with existing ECG equipment
  • Instant results with cloud processing
  • SaaS model - pay only for what you use
Platform Features
Scalable
No processing limits
Secure
HIPAA compliant
Integrated
EHR compatible
Accessible
Web-based access

Ready to Transform Your Cardiac Screening?

Request a demo to see how HeartSciences AI-ECG technology can enhance early detection of heart disease in your practice or health system.

Clinical Evidence Review

Walk through our 23 peer-reviewed publications and clinical validation data.

Platform Demonstration

See the MyoVista Insights cloud platform and device integration in action.

Implementation Planning

Discuss integration with your clinical workflows and EHR systems.

By submitting this form, you agree to our Privacy Policy.